Skip to main content
. 2023 Sep 12;16:2791–2802. doi: 10.2147/DMSO.S425198

Table 1.

Clinical Characteristics Between Two Groups at Baseline

DKD (n=1080) NDKD (n=1579) P
Sex (% female) 573(53.1) 779(49.3) 0.059
Age (years) 60.44±11.62 55.90±10.90 <0.001
Duration of diabetes (years) 8.00(1.00, 4.00) 6.00(2.00, 11.00) <0.001
Smoking (%) 291(26.9) 462(29.3) 0.200
Drinking (%) 238(22.0) 372(23.6) 0.355
Exercise (%) 633(58.6) 913(57.8) 0.968
Medication situation (%)
 Hypoglycemic drugs 968(89.6) 1419(89.9) 0.843
 Insulin 327(30.3) 288(18.2) <0.001
 Lipid-lowering drug 796(73.7) 1127(71.4) 0.435
 Anti-hypertensive drugs 478(44.3) 391(24.8) <0.001
BMI (kg/m²) 26.33±4.22 25.95±4.04 0.019
WC (cm) 88.74±9.97 86.94±9.91 <0.001
VAI 1.52(0.96, 2.48) 1.40 (0.88,2.21) <0.001
LAP 31.60(19.52,50.75) 28.14(16.48,46.99) <0.001
BRI 4.56±1.40 4.25±1.34 <0.001
BMI-SD 0.38(0.18,0.73) 0.34(0.11,0.69) 0.024
WC-SD 1.78±1.01 1.58±0.92 0.174
VAI-SD 0.48(0.03,0.42) 0.33(0.12,0.37) 0.016
LAP-SD 4.49(1.23,11.34) 3.65(0.91,9.85) 0.072
BRI-SD 0.20±0.12 0.25±0.13 0.055
HbA1c (%) 8.47±2.09 8.40±2.06 0.395
SBP (mmHg) 136.50±18.73 130.72±17.44 <0.001
DBP (mmHg) 78.65±11.53 77.02±11.45 <0.001
TC (mg/dL) 193.24±39.42 193.46±38.47 0.887
TG (mg/dL) 126.00 (86.00, 177.00) 117.00 (86.00, 170.00) 0.190
LDL-C (mg/dL) 111.81±33.31 109.56±31.52 0.081
HDL-C (mg/dL) 46.66±12.55 48.85±12.97 <0.001
Scr (mg/dL) 0.95 ±0.27 0.89±0.22 <0.001
Egfr (mL/(min 1.73m2) 77.77(64.61,94.17) 85.13(70.54,99.85) <0.001
UACR (mg/g) 10.36±6.83 14.71±7.55 <0.001

Note: Data are expressed as means ± SD, median (interquartile range) or percentages.

Abbreviations: BMI, body mass index; WC, waist circumference; VAI, visceral adiposity index; LAP, lipid accumulation product; BRI, body roundness index; HbA1c, hemoglobin A1c; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; Scr, serum creatinine; eGFR, estimated glomerular filtration rate.